Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zappia, M.
Right arrow Articles by Quattrone, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zappia, M.
Right arrow Articles by Quattrone, A.
Neurology 1999;52:763
© 1999 American Academy of Neurology


Articles

Loss of long-duration response to levodopa over time in PD

Implications for wearing-off

M. Zappia, MD, R. L. Oliveri, MD, R. Montesanti, MD, M. Rizzo, PhD, D. Bosco, MD, M. Plastino, MD, L. Crescibene, PhD, L. Bastone, PhD, U. Aguglia, MD, A. Gambardella, MD and A. Quattrone, MD

From the Institute of Neurology (Drs. Zappia, Oliveri, Montesanti, Bosco, Plastino, Aguglia, Gambardella, and Quattrone) and the Faculty of Pharmacy (Dr. Rizzo), University of Catanzaro, Italy; and the Institute of Experimental Medicine and Biotechnology (Drs. Oliveri, Crescibene, Bastone, Gambardella, and Quattrone), National Research Council, Piano Lago di Mangone (Cosenza), Italy.

Address correspondence and reprint requests to Dr. Aldo Quattrone, Clinica Neurologica, Facoltà di Medicina, Via T. Campanella, 88100 Catanzaro, Italy.

OBJECTIVE: To determine the modifications of the long-duration response to levodopa in PD over a 1-year period.

BACKGROUND: The development of predictable motor fluctuations in PD has been attributed mainly to modifications over time of the short-duration response to levodopa, whereas the role of the long-duration response has not been widely investigated.

METHODS: In 17 patients with PD the authors examined prospectively both the short-duration response and the long-duration response to levodopa under standardized conditions on two different occasions separated by a period of approximately 1 year (11.7 ± 3.6 months).

RESULTS: At the end of the follow-up period, the short-duration response increased in magnitude but did not change significantly in duration. A total of 24% of patients lost the long-duration response 1 year after their first examination, but a sustained long-duration response could be reestablished by shortening the interdose interval for levodopa intake. Moreover, the duration of the long-duration response after discontinuation of treatment became significantly shorter during 1 year.

CONCLUSION: Modifications of the long-duration response may have a pivotal role in generating a fluctuating response, and suggest that therapeutic strategies based on maintenance of the long-duration response should be sought to avoid the appearance of motor fluctuations.




This article has been cited by other articles:


Home page
Arch NeurolHome page
C. Wider, H. Russmann, J.-G. Villemure, B. Robert, J. Bogousslavsky, P. R. Burkhard, and F. J. G. Vingerhoets
Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation.
Arch Neurol, July 1, 2006; 63(7): 951 - 955.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
E. Moro, R. J. A. Esselink, A. L. Benabid, and P. Pollak
Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation
Brain, November 1, 2002; 125(11): 2408 - 2417.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. Jankovic
Levodopa strengths and weaknesses
Neurology, February 1, 2002; 58(90001): S19 - 32.
[Abstract] [Full Text]


Home page
NeurologyHome page
C. H. Adler
Relevance of motor complications in Parkinson's disease
Neurology, February 1, 2002; 58(90001): S51 - 56.
[Abstract] [Full Text]


Home page
Arch NeurolHome page
A. E. Lang
Surgery for Parkinson Disease: A Critical Evaluation of the State of the Art
Arch Neurol, August 1, 2000; 57(8): 1118 - 1125.
[Full Text] [PDF]


Home page
NeurologyHome page
M. Zappia, R. L. Oliveri, D. Bosco, G. Nicoletti, D. Branca, M. Caracciolo, I. D. Napoli, A. Gambardella, and A. Quattrone
The long-duration response to L-dopa in the treatment of early PD
Neurology, May 23, 2000; 54(10): 1910 - 1915.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by AAN Enterprises, Inc.